CBIS News and Press, Cannabis Science Inc From 10/18/18

Colorado's marijuana market has crested $1B in annual sales as of August , the fastest pace in four years of legalized recreational use of the drug. More news on: Tilray, Inc., Cronos Group, Inc., Canopy Growth Corporation, Healthcare stocks news, Consumer stocks news, News on ETFs, R...

Pot stocks are on watch this morning as legal recreational marijuana sales begin in Canada, with provinces handling their own regulations for sale, growth and taxation. More news on: Tilray, Inc., Cronos Group, Inc., Canopy Growth Corporation, Top stock market news, News on ETFs, Read ...

Pot stocks have perked up in conjunction with Canopy Growth's ( CGC +10.5% ) acquisition of Colorado-based hemp research outfit ebbu. The commencement of legal cannabis use in Canada on Wednesday, October 17, may have something to do with it as well. More news on: Canopy Growth Corporati...

Doctors in England, Wales and Scotland will be able to prescribe cannabis-based medicines for patients beginning November 1. More news on: Canopy Growth Corporation, Medical Marijuana, Inc., Aurora Cannabis Inc., Healthcare stocks news, Consumer stocks news, News on ETFs, Read more ....

Canopy Growth ( CGC -1.3% ) CEO Bruce Linton tells Financial Post during an interview that there is "no chance" licensed cannabis producers will meet consumer demand on day one of legalization on October 17. More news on: Canopy Growth Corporation, Tilray, Inc., Cronos Group, Inc., Con...

IRVINE, CA, Oct. 01, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC:  CBIS ), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the Company has appointed Dr. Joe Wilson, an information technology (IT) and...

IRVINE, CA, Sept. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC:  CBIS ), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the Company has appointed Dr. Joe Wilson, an information technology (IT) and ri...

IRVINE, CA, Sept. 26, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC:  CBIS ), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the Company has re-appointed Dr. Brylyne Chitsunge, Pan-African Ambassador fo...

The fund would play both long and short positions in the marijuana sector, according to the Bloomberg report . At first, the fund would invest in Canadian-listed plays, with the expectation of expanding to U.S. firms should they win approval to list on this country's exchanges. More news ...

Cronos Group (NASDAQ: CRON ) and Canopy Growth (NYSE: CGC ) are up  5%  and  4% , respectively, premarket benefiting from buying in Tilray ( +20% ). More news on: Cronos Group, Inc., Canopy Growth Corporation, Medical Marijuana, Inc., Healthcare stocks news, Consumer stocks ...